184 related articles for article (PubMed ID: 3378275)
1. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
[TBL] [Abstract][Full Text] [Related]
5. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
6. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
7. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
9. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
[TBL] [Abstract][Full Text] [Related]
11. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
12. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N
Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503
[TBL] [Abstract][Full Text] [Related]
14. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
Fraschini F; Scaglione F; Alessandria M; Gattei G
Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
[TBL] [Abstract][Full Text] [Related]
15. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of aztreonam in refractory infections in children].
Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
Pedretti G; Magnani G
G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
[No Abstract] [Full Text] [Related]
18. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
[TBL] [Abstract][Full Text] [Related]
20. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
